TickerFactsScreenerDevelopers

Telomir Pharmaceuticals, Inc. (TELO) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2021: -$138.1K2022: -$937.3K2023: $3.44M2024: $643.0K2025: $5.91M$5.91M
2021Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$5.91M+819.6%
2024$643.0K-81.3%
2023$3.44M+466.8%
2022-$937.3K-578.5%
2021-$138.1K—